Stay updated on Celecoxib Impact on SMN2 in SMA Clinical Trial
Sign up to get notified when there's something new on the Celecoxib Impact on SMN2 in SMA Clinical Trial page.

Latest updates to the Celecoxib Impact on SMN2 in SMA Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a Locations section with Ottawa, Ontario, Canada as a study site and updated the page to revision v3.3.3.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page revision tag changed from v3.2.0 to v3.3.2. This appears to be an internal version update and does not affect study information.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page no longer displays a general government funding and operating status banner. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedNo significant changes detected; only minor visual/layout tweaks with no impact on core content or function. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check103 days agoChange Detected- Replaced the specific term 'Proximal spinal muscular atrophy' with the broader 'Spinal muscular atrophy' and incremented the revision version from v3.1.0 to v3.2.0. - Added a government-operations notice about funding, status, and references to cc.nih.gov and opm.gov. - The content now includes a general operating-status update rather than a prior more specific term.SummaryDifference4%

Stay in the know with updates to Celecoxib Impact on SMN2 in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Celecoxib Impact on SMN2 in SMA Clinical Trial page.